Anti-epileptic drugs and hepatitis C therapy: Real-world experience

Volume: 75, Issue: 4, Pages: 984 - 985
Published: Oct 1, 2021
Abstract
The latest update of the EASL recommendations for HCV treatment provides invaluable information to guide attempts at achieving the WHO goal of elimination.1 Direct-acting antivirals (DAAs) have significantly improved treatment of HCV infection, and almost all patients receiving these drugs achieve sustained virological response (SVR). However, there is still a niche of individuals with HCV who cannot be treated because of drug-drug interactions...
Paper Details
Title
Anti-epileptic drugs and hepatitis C therapy: Real-world experience
Published Date
Oct 1, 2021
Volume
75
Issue
4
Pages
984 - 985
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.